Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-22T21:07:32.638Z Has data issue: false hasContentIssue false

Pecazine (“Pacatal”) Compared with Amylobarbitone Sodium in Anxiety States

Published online by Cambridge University Press:  08 February 2018

Ashley A. Robin*
Affiliation:
Runwell Hospital and Southend General Hospital, Essex

Extract

A review of the literature which is accumulating on the so-called tranquillizing drugs shows:

1. A relatively small number of adequately controlled trials with, in general, more conservative conclusions than those of the much greater number of uncontrolled trials (Foulds, 1958).

2. Diffuseness in patient selection, with subjects often being chosen for behavioural qualities (e.g. overactivity) or general characteristics (e.g. chronicity) rather than for diagnosis.

Type
Original Articles
Copyright
Copyright © Royal College of Psychiatrists, 1959 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

A.M.A. Council on Drugs, New and Non-Official Drugs, 1958. Philadelphia: J. B. Lippencott Co.Google Scholar
Davies, D. L., and Shepherd, M., Lancet, 1955, ii, 117.Google Scholar
Lomas, J., Brit. Med. J., 1957, ii, 78.Google Scholar
The Extra Pharmacopoeia, 1958. 24th edn. London: Pharmaceutical Press.Google Scholar
Meyler, L., Side Effects of Drugs, 1957. Amsterdam: Excerpta Medica Foundation.Google Scholar
Mitchell, P. H., et al., Brit. Med. J., 1957, i, 204.Google Scholar
Raymond, M. J., et al., ibid., 1957, ii, 63.Google Scholar
Scott, P. A. L., J. Ment. Sci., 1955, 101, 163.Google Scholar
Foulds, G. A., ibid., 1958, 104, 259.Google Scholar
Idem and Caine, T. M., ibid., 1958, 104, 722.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.